Evaluating the cost-effectiveness of vaccination programmes: A dynamic perspective

Statistics in Medicine

Volumn 18, Issue 23, 1999, Pages 3263-3282

  Edmunds, W J ^a,b   Medley, G F ^a   Nokes, D J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b PHLS CDSC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DRUG EFFICACY; HEALTH CARE COST; IMMUNIZATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; VACCINATION;

EID: 0033573302     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3     Document Type: Conference Paper

References (31)

1. Arrow, K. J. 'Uncertainty and the welfare economics of medical care', American Economic Review, 53, 941-973 (1963).
2. Weinstein, M. C. and Stason, W. B. 'Foundations of cost-effectiveness analysis for health and medical practices', New England Journal of Medicine, 296, 716-721 (1977).
3. Drummond, M. F., Stoddart, G. L. and Torrance, G. W. Methods for the Economic Evaluation of Health Care Programmes, Oxford Medical Publications, Oxford, 1987.
4. Anderson, R. M. and May, R. M. Infectious Diseases of Humans. Dynamics and Control, Oxford University Press, Oxford, 1991.
5. Nokes, D. J. and Anderson, R. M. 'The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes', Epidemiology and Infection, 101, 1-20 (1988).
6. Fine, P. E. M. 'Herd immunity: history, theory, practice', Epidemiologic Reviews, 15, 265-302 (1993).
7. Anderson, R. M. and Nokes, D. J. 'Epidemiological approaches: mathematical models of transmission and control', in Holland, W. W., Detels, R. and Knox, E. G. (eds), Oxford Textbook of Public Health, Oxford University Press, Oxford, 1996.
8. Medley, G. F. 'Conflicts between the individual and communities in treatment and control', in Isham, V. and Medley, G. F. (eds), Models for Infectious Human Diseases. Their Structure and Relation to Data, Cambridge University Press, Cambridge, 1996, pp. 331-343.
9. Halloran, M. E., Haber, M., Longini, I. M. and Struchiner, C. J. 'Direct and indirect effects in vaccine efficacy and effectiveness', American Journal of Epidemiology, 133, 323-331 (1991).
10. Haber, M., Longini, I. M. and Halloran, M. E. 'Measures of the effects of vaccination in a randomly mixing population', International Journal of Epidemiology, 20, 300-310 (1991).
11. Longini, I. M., Halloran, M. E., Haber, M. and Chen, R. T. 'Measuring vaccine efficacy from epidemics of acute infectious agents', Statistics in Medicine, 12, 249-263 (1993).
12. Clemens, J., Brenner, R., Rao, M., Tafari, N. and Lowe, C. 'Evaluating new vaccines for developing countries. Efficacy or effectiveness?', Journal of the American Medical Association, 275, 390-397 (1996).
13. Anderson, R. M. and May, R. M. 'Vaccination and herd immunity to infectious diseases', Nature, 318, 323-329 (1985).
14. Bloom, B. S., Hillman, A. L., Fendrick, A. M. and Schwartz, J. S. 'A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis', Annals of Internal Medicine, 118, 298-306 (1993).
15. Margolis, H. S., Coleman, P. J., Brown, R. E., Mast, E. E., Sheingold, S. H. and Arevalo, J. A. 'Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations', Journal of the American Medical Association, 274, 1201-1208 (1995).
16. Grenfell, B. T. and Anderson, R. M. 'The estimation of age-related rates of infection from case notifications and serological data', Journal of Hygiene, Cambridge, 95, 419-436 (1985).
17. Anderson, R. M. and May, R. M. 'Vaccination against rubella and measles: quantiative investigations of different policies', Journal of Hygiene, Cambridge, 90, 259-325 (1983).
18. Andersen, R. M. and Grenfell, B. T. 'Quantitative investigations of different vaccination policies for the control of congenital rubella syndrom (CRS) in the United Kingdom', Journal of Hygiene, London, 96, 305-333 (1986).
19. Mullooly, J. P., Bennett, M. D., Hornbrook, M. C., Barker, W. H., Williams, W. W., Patriarca, P. A., and Rhodes, P. H. 'Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization', Annals of Internal Medicine, 121, 947-952 (1994).
20. Nichol, K. L., Margolis, K. L., Wuorenma, R. N., and Von Sternberg, T. 'The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community', New England Journal of Medicine, 331, 778-784 (1994).
21. Babad, H. R., Nokes, D. J., Gay, N. J., Miller, E., Morgan-Capner, P. and Anderson, R. M. 'Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options', Epidemiology and Infection, 114, 319-344 (1995).
22. Hollinger, F. B. and the North American Regional Study Group 'Controlling hepatitis B virus transmission in North America', Vaccine, 8(suppl). s122-s128 (1990).
23. Margolis, H. S., Coleman, P. J. and Mast, E. E. 'Cost-effectiveness of hepatitis-B virus immunization', Journal of the American Medical Association, 275, 909 (1996).
24. Lau, Y., Chow, C. and Leung, T. 'Changing epidemiology of measles in Hong Kong from 1961 to 1990 - Impact of a measles vaccination program', Journal of Infectious Diseases, 165, 1111-1115 (1992).
25. Ukkonen, P. and Von Bonsdorff, C. H. 'Rubella immunity and morbidity: effects of vaccination in Finland', Scandanavian Journal of Infectious Diseases, 20, 255-259 (1988).
26. Anderson, R. M., Crombie, J. A. and Grenfell, B. T. 'The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization', Epidemiology and Infection, 99, 65-84 (1987).
27. Edmunds, W. J., Medley, G. F. and Nokes, D. J. 'Vaccination against hepatitis B virus (HBV) in highly endemic areas: waning vaccine induced immunity and the need for booster doses', Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 436-440 (1996).
28. Van Doorslaer, E., Tormans, G. and Van Damme, P. 'Cost-effectiveness analysis of vaccination against hepatitis A in travellers', Journal of Medical Virology, 44, 463-469 (1994).
29. Edmunds, W. J., Medley, G. F. and Nokes, D. J. 'The transmission dynamics and control of hepatitis B virus in The Gambia', Statistics in Medicine, 15, 2215-2233 (1996).
30. Trnka, L., Dankova, D. and Svandova, E. 'Six years' experience with the discontinuation of BCG vaccination. 2. Cost and benefit of mass BCG vaccination', Tubercle and Lung Disease, 74, 288-292 (1993).
31. Watson, J. M. 'BCG - mass or selective vaccination?', Journal of Hospital Infection, 30(Suppl), 508-513 (1995).